Page last updated: 2024-08-23

mifepristone and Dyslipidemias

mifepristone has been researched along with Dyslipidemias in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barr, RJ; Bean, JS; Carson, MW; Clawson, D; Coghlan, MJ; Condon, B; Dill, MJ; Kohlman, DT; Luz, JG; Maletic, M; Pustilnik, A; Sindelar, DK1
Athimulam, S; Bancos, I; Delivanis, DA1

Other Studies

2 other study(ies) available for mifepristone and Dyslipidemias

ArticleYear
Indole Glucocorticoid Receptor Antagonists Active in a Model of Dyslipidemia Act via a Unique Association with an Agonist Binding Site.
    Journal of medicinal chemistry, 2015, Aug-27, Volume: 58, Issue:16

    Topics: Animals; Binding Sites; Cricetinae; Crystallography, X-Ray; Diet, High-Fat; Dyslipidemias; Female; Ligands; Lipids; Mesocricetus; Models, Molecular; Protein Conformation; Rats; Rats, Wistar; Receptors, Glucocorticoid; Structure-Activity Relationship; Sulfonamides

2015
Modern Management of Mild Autonomous Cortisol Secretion.
    Clinical pharmacology and therapeutics, 2019, Volume: 106, Issue:6

    Topics: 14-alpha Demethylase Inhibitors; Adrenal Cortex Neoplasms; Adrenal Insufficiency; Adrenalectomy; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 2; Disease Management; Dyslipidemias; Enzyme Inhibitors; Glucocorticoids; Hormone Antagonists; Humans; Hydrocortisone; Hypertension; Incidental Findings; Ketoconazole; Metyrapone; Mifepristone; Mortality; Obesity; Osteoporosis; Postoperative Hemorrhage; Risk; Saliva; Severity of Illness Index

2019